{"id":13274,"date":"2019-05-21T07:29:25","date_gmt":"2019-05-21T11:29:25","guid":{"rendered":"https:\/\/medicarereport.org\/?p=13274"},"modified":"2019-05-21T07:29:25","modified_gmt":"2019-05-21T11:29:25","slug":"how-does-prescription-drug-spending-and-use-compare-across-large-employer-plans-medicare-part-d-and-medicaid","status":"publish","type":"post","link":"https:\/\/medicarereport.org\/?p=13274","title":{"rendered":"How Does Prescription Drug Spending and Use Compare Across Large Employer Plans, Medicare Part D, and Medicaid?"},"content":{"rendered":"

(By Juliette Cubanski, Matthew Rae, Katherine Young, and Anthony Damico for Kaiser Family Foundation)<\/p>\n

Prescription drug costs are a pressing concern for both consumers and policymakers. Rising drug prices affect patients\u2019 out-of-pocket costs as well as the budgets of private and public payers, though the challenges vary by payer. This analysis compares prescription drug spending and use in large private employer plans, Medicare Part D, and Medicaid, based primarily on claims data by payer, which does not account for rebates. Rebates differ by payer, and are\u00a0estimated\u00a0to be\u00a0larger for Medicaid\u00a0than Medicare Part D or private employers.\u00a0 Continue reading analysis here…<\/a><\/p>\n

\"\"<\/a><\/p>\n

Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link\u2019s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org.<\/pre>\n","protected":false},"excerpt":{"rendered":"
(By Juliette Cubanski, Matthew Rae, Katherine Young, and Anthony Damico for Kaiser Family Foundation) Prescription drug costs are a pressing<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[21,16,15],"tags":[],"class_list":["post-13274","post","type-post","status-publish","format-standard","hentry","category-health-care-finance","category-medicaid","category-part-dprescription-drugs"],"_links":{"self":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/13274","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=13274"}],"version-history":[{"count":1,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/13274\/revisions"}],"predecessor-version":[{"id":13275,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/13274\/revisions\/13275"}],"wp:attachment":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=13274"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=13274"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=13274"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}